Mrs Kimberly Baker Alten, APRN, BC, MSN, FNP | |
287 E Hunt Hwy Ste 105, San Tan Valley, AZ 85143-5096 | |
(480) 677-8282 | |
(480) 535-0962 |
Full Name | Mrs Kimberly Baker Alten |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Family |
Location | 287 E Hunt Hwy Ste 105, San Tan Valley, Arizona |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326175704 | NPI | - | NPPES |
Entity Name | Good Health Medical, Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144764432 PECOS PAC ID: 3779680962 Enrollment ID: O20070523000237 |
News Archive
Otsuka Pharmaceutical Co., Ltd. today announced it has become the first company in the world to obtain regulatory approval for a pharmacological treatment of autosomal dominant polycystic kidney disease (ADPKD). Samsca (generic name: tolvaptan) has been approved in Japan in 7.5-mg and 15-mg tablet forms for extended use for the additional indication of ADPKD. Also, the new dosage form of 30-mg Samsca tablets has received approval for the indication of ADPKD.
HHS Secretary Tommy G. Thompson today approved a request by the state of Arkansas to expand prenatal care to low-income pregnant women and their unborn children under the State Children's Health Insurance Program (SCHIP).
A new genome-wide association study estimates the number of different places in the human genome that are involved in schizophrenia.
Patients with gastrointestinal stromal tumours (GIST) can now take action at an earlier stage of this rare form of cancer to reduce the risk of their disease returning following surgery. Novartis Pharmaceuticals Canada announced today that Gleevec* (imatinib mesylate) has received conditional approval by Health Canada for the adjuvant (post-surgical) treatment of adult patients who are at intermediate to high risk of disease recurrence following the surgical removal of GIST.
Could your electronics be making you fat? According to University of Houston researchers, a common flame retardant used to keep electronics from overheating may be to blame.
› Verified 9 days ago
Entity Name | Ponderosa Family Care Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144535626 PECOS PAC ID: 1456548015 Enrollment ID: O20101208000388 |
News Archive
Otsuka Pharmaceutical Co., Ltd. today announced it has become the first company in the world to obtain regulatory approval for a pharmacological treatment of autosomal dominant polycystic kidney disease (ADPKD). Samsca (generic name: tolvaptan) has been approved in Japan in 7.5-mg and 15-mg tablet forms for extended use for the additional indication of ADPKD. Also, the new dosage form of 30-mg Samsca tablets has received approval for the indication of ADPKD.
HHS Secretary Tommy G. Thompson today approved a request by the state of Arkansas to expand prenatal care to low-income pregnant women and their unborn children under the State Children's Health Insurance Program (SCHIP).
A new genome-wide association study estimates the number of different places in the human genome that are involved in schizophrenia.
Patients with gastrointestinal stromal tumours (GIST) can now take action at an earlier stage of this rare form of cancer to reduce the risk of their disease returning following surgery. Novartis Pharmaceuticals Canada announced today that Gleevec* (imatinib mesylate) has received conditional approval by Health Canada for the adjuvant (post-surgical) treatment of adult patients who are at intermediate to high risk of disease recurrence following the surgical removal of GIST.
Could your electronics be making you fat? According to University of Houston researchers, a common flame retardant used to keep electronics from overheating may be to blame.
› Verified 9 days ago
Entity Name | Social Work Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538573282 PECOS PAC ID: 3678793460 Enrollment ID: O20140929002480 |
News Archive
Otsuka Pharmaceutical Co., Ltd. today announced it has become the first company in the world to obtain regulatory approval for a pharmacological treatment of autosomal dominant polycystic kidney disease (ADPKD). Samsca (generic name: tolvaptan) has been approved in Japan in 7.5-mg and 15-mg tablet forms for extended use for the additional indication of ADPKD. Also, the new dosage form of 30-mg Samsca tablets has received approval for the indication of ADPKD.
HHS Secretary Tommy G. Thompson today approved a request by the state of Arkansas to expand prenatal care to low-income pregnant women and their unborn children under the State Children's Health Insurance Program (SCHIP).
A new genome-wide association study estimates the number of different places in the human genome that are involved in schizophrenia.
Patients with gastrointestinal stromal tumours (GIST) can now take action at an earlier stage of this rare form of cancer to reduce the risk of their disease returning following surgery. Novartis Pharmaceuticals Canada announced today that Gleevec* (imatinib mesylate) has received conditional approval by Health Canada for the adjuvant (post-surgical) treatment of adult patients who are at intermediate to high risk of disease recurrence following the surgical removal of GIST.
Could your electronics be making you fat? According to University of Houston researchers, a common flame retardant used to keep electronics from overheating may be to blame.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Kimberly Baker Alten, APRN, BC, MSN, FNP 2902 W Hughes Dr, Payson, AZ 85541-3455 Ph: (626) 374-7672 | Mrs Kimberly Baker Alten, APRN, BC, MSN, FNP 287 E Hunt Hwy Ste 105, San Tan Valley, AZ 85143-5096 Ph: (480) 677-8282 |
News Archive
Otsuka Pharmaceutical Co., Ltd. today announced it has become the first company in the world to obtain regulatory approval for a pharmacological treatment of autosomal dominant polycystic kidney disease (ADPKD). Samsca (generic name: tolvaptan) has been approved in Japan in 7.5-mg and 15-mg tablet forms for extended use for the additional indication of ADPKD. Also, the new dosage form of 30-mg Samsca tablets has received approval for the indication of ADPKD.
HHS Secretary Tommy G. Thompson today approved a request by the state of Arkansas to expand prenatal care to low-income pregnant women and their unborn children under the State Children's Health Insurance Program (SCHIP).
A new genome-wide association study estimates the number of different places in the human genome that are involved in schizophrenia.
Patients with gastrointestinal stromal tumours (GIST) can now take action at an earlier stage of this rare form of cancer to reduce the risk of their disease returning following surgery. Novartis Pharmaceuticals Canada announced today that Gleevec* (imatinib mesylate) has received conditional approval by Health Canada for the adjuvant (post-surgical) treatment of adult patients who are at intermediate to high risk of disease recurrence following the surgical removal of GIST.
Could your electronics be making you fat? According to University of Houston researchers, a common flame retardant used to keep electronics from overheating may be to blame.
› Verified 9 days ago
Laura Babb, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 287 E Hunt Hwy, Suite 105, San Tan Valley, AZ 85143 Phone: 480-677-8282 Fax: 480-677-8283 | |
Paige Figa Church, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 287 E Hunt Hwy Ste 105, San Tan Valley, AZ 85143 Phone: 480-677-8282 Fax: 480-535-0962 | |
Lisa Wakefield, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1148 W Fruit Tree Ln, San Tan Valley, AZ 85143 Phone: 313-478-8274 | |
Christina Joyave, AGNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 37100 N Gantzel Rd, San Tan Valley, AZ 85140 Phone: 480-821-3616 | |
John Cruz Ortiz Jr., ACNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 37000 N Gantzel Rd, San Tan Valley, AZ 85140 Phone: 480-394-4000 | |
Robert Antonio Meyer, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 37219 N Fossil Butte Ct, San Tan Valley, AZ 85140 Phone: 909-446-6778 | |
Tara L Luke, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 287 E Hunt Hwy Ste 105, San Tan Valley, AZ 85143 Phone: 480-677-8282 |